Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection
OwnerJonathan L. Koff, Jay A. Nadelinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating a viral infection in an individual. The methods generally involve administering to an individual an effective amount of an epidermal growth factor receptor (EGF-R) inhibitor.
Claims53
A method of treating a viral infection in an individual, the method comprising administering to the individual an effective amount of an epidermal growth factor receptor (EGF-R) antagonist, wherein the viral infection is caused by a virus of the family Picornaviridae, Orthomyxoviridae, Paramyxoviridae, Coronaviridae, Adenoviridae, Reoviridae, Caliciviridae, Astroviridae, Retroviridae, Herpesviridae, or Papillomaviridae.
A method of treating respiratory virus-induced exacerbation of a chronic lung disease in an individual, the method comprising administering to the individual an effective amount of an epidermal growth factor receptor (EGF-R) antagonist.
Dependencies are inferred from the claim text.